` Comparison: 2126, PNEXF - Alpha Spread

2126
vs
PNEXF

Over the past 12 months, JW (Cayman) Therapeutics Co Ltd has significantly outperformed PNEXF, delivering a return of +249% compared to the PNEXF's 0% growth.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
2126
PNEXF
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

Intrinsic Value
3.92 HKD
Overvaluation 23%
Intrinsic Value
Price
PNEXF Intrinsic Value
Not Available
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
5.09 HKD
Pharnext SCA
OTC:PNEXF
999 999.9999 USD
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
2126, PNEXF

2126
PNEXF
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
JW (Cayman) Therapeutics Co Ltd
Revenue
Pharnext SCA
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
2126, PNEXF

2126
PNEXF
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
Pharnext SCA
OTC:PNEXF
What is Free Cash Flow?

Gross Margin

JW (Cayman) Therapeutics Co Ltd
48.9%
PNEXF
0%

Operating Margin

JW (Cayman) Therapeutics Co Ltd
-290.1%
PNEXF
-17 526.7%

Net Margin

JW (Cayman) Therapeutics Co Ltd
-373.3%
PNEXF
-21 040%

FCF Margin

JW (Cayman) Therapeutics Co Ltd
-220.5%
PNEXF
-15 953.3%

ROE

JW (Cayman) Therapeutics Co Ltd
-41.4%
PNEXF
114.6%

ROA

JW (Cayman) Therapeutics Co Ltd
-30.9%
PNEXF
-391.1%

ROIC

JW (Cayman) Therapeutics Co Ltd
-48.9%
PNEXF
3 092.9%

ROCE

JW (Cayman) Therapeutics Co Ltd
-29.6%
PNEXF
275.4%

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
2126, PNEXF

Loading

Performance Gap
2126, PNEXF

Loading
2126
PNEXF
Difference
www.alphaspread.com

Performance By Year
2126, PNEXF

Loading
2126
PNEXF
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 2126 to other stocks
Unlock Full Access to Alpha Spread
Create Free Account